Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:13 pm Sale |
2022-12-31 | 13G | LianBio LIANY |
Venrock Healthcare Capital Partners II, L.P. | 4,793,047 4.400% |
-585,294 (-10.88%) |
Filing History |
| 2023-02-14 4:09 pm Sale |
2022-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Venrock Healthcare Capital Partners II, L.P. | 3,867,749 9.300% |
-197,251 (-4.85%) |
Filing History |
| 2023-02-14 4:08 pm Sale |
2022-12-31 | 13G | Provention Bio, Inc. PRVB |
Venrock Healthcare Capital Partners II, L.P. | 1,118,653 1.300% |
-2,725,143 (-70.90%) |
Filing History |
| 2023-02-14 4:07 pm Sale |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Venrock Healthcare Capital Partners II, L.P. | 1,770,705 3.700% |
-1,109,391 (-38.52%) |
Filing History |
| 2023-02-14 4:07 pm Purchase |
2022-12-31 | 13G | Annexon, Inc. ANNX |
Venrock Healthcare Capital Partners II, L.P. | 4,929,000 9.990% |
3,000,523 (+155.59%) |
Filing History |
| 2023-02-14 4:07 pm Purchase |
2022-12-31 | 13G | GH Research PLC GHRS |
Venrock Healthcare Capital Partners II, L.P. | 3,517,125 6.800% |
696,624 (+24.70%) |
Filing History |
| 2023-02-14 4:07 pm Sale |
2022-12-31 | 13G | aTyr Pharma, Inc. ATYR |
Venrock Healthcare Capital Partners II, L.P. | 1,171,436 4.000% |
-393,564 (-25.15%) |
Filing History |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | Savara Inc. SVRA |
Venrock Healthcare Capital Partners II, L.P. | 6,351,531 5.600% |
6,351,531 (New Position) |
Filing History |
| 2023-02-14 4:05 pm Purchase |
2022-12-31 | 13G | Celcuity Inc. CELC |
Venrock Healthcare Capital Partners II, L.P. | 2,171,125 9.990% |
513,392 (+30.97%) |
Filing History |
| 2022-11-14 4:11 pm Purchase |
2022-11-03 | 13G | Savara Inc. SVRA |
Venrock Healthcare Capital Partners II, L.P. | 6,187,282 5.400% |
6,187,282 (New Position) |
Filing History |
| 2022-10-28 4:05 pm Sale |
2022-10-25 | 13G | TRICIDA INC TCDAQ |
Venrock Healthcare Capital Partners II, L.P. | 2,982,528 5.400% |
-5,899,349 (-66.42%) |
Filing History |
| 2022-09-28 9:20 pm Purchase |
2022-09-26 | 13G | TRICIDA INC TCDAQ |
Venrock Healthcare Capital Partners II, L.P. | 8,881,877 16.000% |
3,016,717 (+51.43%) |
Filing History |
| 2022-07-08 4:05 pm Purchase |
2022-04-06 | 13G | VistaGen Therapeutics, Inc. VTGN |
Venrock Healthcare Capital Partners II, L.P. | 689,910 10.000% |
155,000 (+28.98%) |
Filing History |
| 2022-06-23 4:05 pm Purchase |
2022-06-13 | 13G | Annexon, Inc. ANNX |
Venrock Healthcare Capital Partners II, L.P. | 1,928,477 5.000% |
1,928,477 (New Position) |
Filing History |
| 2022-06-23 06:02 am Purchase |
2022-06-13 | 13G | DBV Technologies S.A. DBVT |
Venrock Healthcare Capital Partners II, L.P. | 470,141 9.900% |
470,141 (New Position) |
Filing History |
| 2022-06-06 5:31 pm Purchase |
2022-06-01 | 13G | TRICIDA INC TCDAQ |
Venrock Healthcare Capital Partners II, L.P. | 5,865,160 10.600% |
2,370,309 (+67.82%) |
Filing History |
| 2022-05-27 4:05 pm Purchase |
2022-05-17 | 13G | GH Research PLC GHRS |
Venrock Healthcare Capital Partners II, L.P. | 2,820,501 5.400% |
2,820,501 (New Position) |
Filing History |
| 2022-05-25 5:23 pm Purchase |
2022-05-15 | 13G | Celcuity Inc. CELC |
Venrock Healthcare Capital Partners II, L.P. | 1,657,733 9.990% |
1,657,733 (New Position) |
Filing History |
| 2022-05-23 4:30 pm Purchase |
2022-05-12 | 13G | Akouos, Inc. AKUS |
Venrock Healthcare Capital Partners II, L.P. | 2,391,545 6.900% |
2,391,545 (New Position) |
Filing History |
| 2022-04-29 4:05 pm Purchase |
2022-04-19 | 13G | Inozyme Pharma, Inc. INZY |
Venrock Healthcare Capital Partners II, L.P. | 4,065,000 9.800% |
4,065,000 (New Position) |
Filing History |